GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cybin Inc (FRA:R7E1) » Definitions » YoY Rev. per Sh. Growth

Cybin (FRA:R7E1) YoY Rev. per Sh. Growth : 0.00% (As of Dec. 2023)


View and export this data going back to 2020. Start your Free Trial

What is Cybin YoY Rev. per Sh. Growth?

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months. Cybin's YoY Rev. per Sh. Growth for the quarter that ended in Dec. 2023 was 0.00%.

Cybin's Revenue per Share for the three months ended in Dec. 2023 was €0.00.

Cybin YoY Rev. per Sh. Growth Historical Data

The historical data trend for Cybin's YoY Rev. per Sh. Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cybin YoY Rev. per Sh. Growth Chart

Cybin Annual Data
Trend Mar20 Mar21 Mar22 Mar23
YoY Rev. per Sh. Growth
- - -100.00 -

Cybin Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
YoY Rev. per Sh. Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Cybin YoY Rev. per Sh. Growth Calculation

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months.

Cybin's YoY Rev. per Sh. Growth for the fiscal year that ended in Mar. 2023 is calculated as:

YoY Rev. per Sh. Growth (A: Mar. 2023 )
=(Revenue per Share (A: Mar. 2023 )-Revenue per Share (A: Mar. 2022 ))/ | Revenue per Share (A: Mar. 2022 ) |
=(0-0)/ | 0 |
=N/A %

Cybin's YoY Rev. per Sh. Growth for the quarter that ended in Dec. 2023 is calculated as:

YoY Rev. per Sh. Growth (Q: Dec. 2023 )
=(Revenue per Share (Q: Dec. 2023 )-Revenue per Share (Q: Dec. 2022 )) / | Revenue per Share (Q: Dec. 2022 )) |
=(0-0)/ | 0 |
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cybin YoY Rev. per Sh. Growth Related Terms

Thank you for viewing the detailed overview of Cybin's YoY Rev. per Sh. Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Cybin (FRA:R7E1) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cybin Inc (FRA:R7E1) » Definitions » YoY Rev. per Sh. Growth
Comparable Companies
TSX:FRX TSX:SVA TSX:ONC NEOE:MMED TSX:EPRX XCNQ:DTC TSXV:NGEN TSX:BCT XCNQ:MSET TSXV:ARCH OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
CYBN:USA CYBN:Canada
Address
100 King Street West, Suite 5600, Toronto, ON, CAN, M5X 1C9
Website
https://www.cybin.com
Cybin Inc is a biopharmaceutical company involved in creating safe and effective therapeutics for patients to address a multitude of mental health issues. The company is focused on advancing psychedelic-based therapies, delivery mechanisms, novel compounds and protocols as potential treatments for various psychiatric and neurological conditions.

Cybin (FRA:R7E1) Headlines

No Headlines